Exor (ENXTAM:EXO) has quietly slipped over the past year, with shares down around 23% even as its underlying holdings like Ferrari and Stellantis keep executing. That gap is exactly what value focused ...

Philips resolved the Respironics litigation, settling for $1.1 billion. And Exor decided to boost its stake in the company. Supportive shareholders' remuneration is linked to Exor's portfolio results, ...

Exor announced the sale of a 4% stake in Ferrari to institutional investors, valued at €3 billion. This strategic move aims to diversify Exor's portfolio. Exor also plans a €1 billion buyback program ...

Shares sold at 450 euros each, bookrunner says Ferrari bought back 300 million euros of its own shares Exor will retain 20% stake, 30% voting rights in Ferrari The sale will help Exor reduce ...